药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Metacycline
Sodium zirconium cyclosilicate
Sodium zirconium cyclosilicate can cause a decrease in the absorption of Lopinavir resulting in a reduced serum concentration and potentially a decrease in efficacy.
Metacycline
Dexrabeprazole
Dexrabeprazole can cause a decrease in the absorption of Lopinavir resulting in a reduced serum concentration and potentially a decrease in efficacy.
Metacycline
Dexlansoprazole
Dexlansoprazole can cause a decrease in the absorption of Lopinavir resulting in a reduced serum concentration and potentially a decrease in efficacy.
Metacycline
Salvianolic acid A
Salvianolic acid A can cause a decrease in the absorption of Lopinavir resulting in a reduced serum concentration and potentially a decrease in efficacy.
Metacycline
Aluminium phosphate
Aluminium phosphate can cause a decrease in the absorption of Lopinavir resulting in a reduced serum concentration and potentially a decrease in efficacy.
Metacycline
Calcium silicate
Calcium silicate can cause a decrease in the absorption of Lopinavir resulting in a reduced serum concentration and potentially a decrease in efficacy.
Metacycline
Niperotidine
Niperotidine can cause a decrease in the absorption of Lopinavir resulting in a reduced serum concentration and potentially a decrease in efficacy.
Metacycline
Aloglutamol
Aloglutamol can cause a decrease in the absorption of Lopinavir resulting in a reduced serum concentration and potentially a decrease in efficacy.
Metacycline
Aluminium glycinate
Aluminium glycinate can cause a decrease in the absorption of Lopinavir resulting in a reduced serum concentration and potentially a decrease in efficacy.
Metacycline
Magnesium peroxide
Magnesium peroxide can cause a decrease in the absorption of Lopinavir resulting in a reduced serum concentration and potentially a decrease in efficacy.
Metacycline
Hydrotalcite
Hydrotalcite can cause a decrease in the absorption of Lopinavir resulting in a reduced serum concentration and potentially a decrease in efficacy.
Metacycline
Aluminium acetoacetate
Aluminium acetoacetate can cause a decrease in the absorption of Lopinavir resulting in a reduced serum concentration and potentially a decrease in efficacy.
Metacycline
Magnesium silicate
Magnesium silicate can cause a decrease in the absorption of Lopinavir resulting in a reduced serum concentration and potentially a decrease in efficacy.
Metacycline
Bismuth subnitrate
Bismuth subnitrate can cause a decrease in the absorption of Lopinavir resulting in a reduced serum concentration and potentially a decrease in efficacy.
Metacycline
Lavoltidine
Lavoltidine can cause a decrease in the absorption of Lopinavir resulting in a reduced serum concentration and potentially a decrease in efficacy.
Metacycline
Lafutidine
Lafutidine can cause a decrease in the absorption of Lopinavir resulting in a reduced serum concentration and potentially a decrease in efficacy.
Metacycline
Magaldrate
Magaldrate can cause a decrease in the absorption of Lopinavir resulting in a reduced serum concentration and potentially a decrease in efficacy.
Metacycline
Roxatidine acetate
Roxatidine acetate can cause a decrease in the absorption of Lopinavir resulting in a reduced serum concentration and potentially a decrease in efficacy.
Metacycline
Metiamide
Metiamide can cause a decrease in the absorption of Lopinavir resulting in a reduced serum concentration and potentially a decrease in efficacy.
Metacycline
Calcium carbonate
Calcium carbonate can cause a decrease in the absorption of Lopinavir resulting in a reduced serum concentration and potentially a decrease in efficacy.